Marie Wernecke, Fabian Stoll, Jonas Wagner, Svenja Meyhfer: The authors declare that they have no conflict of interest
Table 2 below summarizes key GLP-1 drugs with their indications and typical insurance coverage context
Contains premium low molecular weight thymus extract from ovine (sheep)
Author contributions NF, ABK, CC designed research, NF, JL, AWB, CVM, IBL, and ABK performed research, NF analyzed the data, GMK provided input to the research, NF and CC wrote the paper
A significantly elevated level of 3-CT in the autism cerebellum and BA22 is a novel finding indicative of a chronic neuroinflammatory state in these regions
Tirzepatide maintenance For Zepbound, the FDA labeling lists 5 mg, 10 mg, or 15 mg once weekly as maintenance doses